Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Claritas Pharmaceuticals, Inc. (CLAZF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.01680.0000 (0.00%)
At close: 03:39PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0168
Open0.0130
BidN/A x N/A
AskN/A x N/A
Day's Range0.0168 - 0.0168
52 Week Range0.0039 - 0.1900
Volume10
Avg. Volume4,515
Market CapN/A
Beta (5Y Monthly)2.60
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    IIROC Trading Halt - CLAS

    The following issues have been halted by IIROC:

  • CNW Group

    IIROC Trading Halt - CLAS.WT.B

    The following issues have been halted by IIROC:

  • GlobeNewswire

    Claritas Announces Approval from OTC to Up-List to OTCQB

    SAN FRANCISCO, CA and TORONTO, ON, April 07, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE EXCHANGE: CLAS and OTC: CLAZF) (the "Company" or "Claritas") is pleased to announce that it has obtained approval from the OTC Markets Group for listing of its Common Shares on the OTCQB. The Company will provide an update regarding the exact date on which its Common Shares will begin trading on the OTCQB under the ticker symbol "CLAZF". Highlights Claritas has received approval from

Advertisement
Advertisement